Image

Lay-Delivered Behavioral Activation in Senior Centers

Lay-Delivered Behavioral Activation in Senior Centers

Recruiting
60 years and older
All
Phase N/A

Powered by AI

Overview

In response to large numbers of senior center clients who suffer untreated depression and the dearth of geriatric mental health providers, the investigators have simplified Behavioral Activation to be delivered by lay volunteers ("Do More, Feel Better"; DMFB). The focus of Behavioral Activation is to guide clients to reengage in daily pleasant and rewarding activities, and reduce depressive symptoms. If the investigators can show that the lay delivery model has positive impact in comparison to MSW-delivered Behavioral Activation, the investigators will have identified an effective intervention that can be used by a large untapped workforce of older adult volunteers across the nation.

Description

This Collaborative R01 application (UW, Cornell, USF) proposes to conduct an effectiveness trial of lay-delivered Behavioral Activation ("Do More, Feel Better"; DMFB), in comparison to MSW-delivered Behavioral Activation (MSW BA), for depressed (PHQ-9>10 and Ham-D>14) older (60+) senior center clients. The primary aim tests the effectiveness of DMFB, in comparison to MSW BA, on increasing overall activity level (target) and reducing depression symptoms. The investigators will test whether increased activity level predicts greater reduction in depression severity and whether increased activity's impact on depression is non-inferior across conditions. Secondarily, the investigators will test hypotheses associated with overall functioning, satisfaction with treatment, and client-level moderators. Lastly the investigators will explore longer-term client outcomes, delivery cost, and preparing for sustainability by exploring client, provider, and center factors related to intervention fidelity.

Eligibility

Client Participants (anticipated enrollment: 288)

Inclusion Criteria:

Referral to study (stage 1):

  1. Age ≥ 60 years.
  2. Attends one of 18 participating Seattle, NYC, or Tampa senior centers.
  3. Patient Health Questionnaire (PHQ-9) score of ≥10 via routine screening.

Research assessment (stage 2):

  1. Clinically-assessed HAM-D>14
  2. Mini-Mental Status Exam (MMSE) ≥ 24 OR modified Telephone Interview for Cognitive Status (mTICS) ≥ 19
  3. Off antidepressants or on a stable dose for 12 weeks.
  4. Capacity to provide written consent for both research assessment and the BA intervention.

Client Participants Exclusion Criteria:

  1. Current active suicidal ideation.
  2. Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or generalized anxiety disorder by SCID-V (Structure Clinical Interview for DSM-V).
  3. Severe or life-threatening medical illness (e.g., end stage organ failure).
  4. Inability to speak English.

Volunteer Participants (anticipated enrollment: 36) Inclusion Criteria

  1. Age ≥ 60 years.
  2. Attends one of the participating Seattle, NYC, or Tampa-area senior centers.

Volunteer Participants Exclusion Criteria

  1. Current major depressive disorder, alcohol or substance abuse, or manic, hypomanic, or psychotic symptoms (SCID-V);
  2. Mini-Mental Status Exam (MMSE) ≥ 24 OR modified Telephone Interview for Cognitive Status (mTICS) ≥ 19;
  3. Inability to speak and read English.

Clinician Participants (anticipated enrollment: 36) Inclusion Criteria

  1. Master's degree in social work, counseling, marriage/family, or other clinical mental health degree
  2. English Speaking
  3. Capacity to provide consent for all study procedures
  4. Willing to audio record study sessions for supervision and evaluation

Clinician Participants Exclusion Criteria

  1. Non-English speaking
  2. Does not hold a Master's degree in social work, counseling, marriage/family, or other clinical mental health degree
  3. Unable to provide consent
  4. Unwilling to audio record study sessions for supervision and evaluation

Study details
    Depression

NCT04621877

University of Washington

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.